Skip to main content
Press release August 11, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Inc. (ZYME)

VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in
View original release